Silver

Silver

SCHEMBL5376950

CC(C)c1cc(C(C)C)c(S(=O)(=O)[O-])c(C(C)C)c1[N+](=O)[O-].[Ag+]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.34
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
NPY1R P25929 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.32
CYP19A1 P11511 1/20 0.30
PDK1 Q15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5388305 0.84 FABP3 (0.49) FABP3FABP4FABP5MEN1TP53
SCHEMBL178363 0.84 FABP3 (0.49) FABP3FABP4FABP5MEN1TP53
SCHEMBL5376952 0.83 FABP3 (0.47) FABP3FABP4FABP5MEN1TP53
SCHEMBL2955944 0.82 NR1I2 (0.32) MEN1TP53CYP3A4MAPTTSHR
SCHEMBL9004701 0.81 PDK1 (0.37) MEN1TP53CYP3A4MAPTTSHR
SCHEMBL5378739 0.81 HPRT1 (0.36) MEN1TP53CYP3A4MAPTTSHR
SCHEMBL107210 0.75 ALDH1A1 (0.35) MEN1TSHRKMT2ATDP1ALDH1A1
SCHEMBL10293225 0.73 PDK1 (0.33) TSHRTDP1ALDH1A1HPGDNPSR1
SCHEMBL27583174 0.72 FABP3 (0.38) FABP3FABP4FABP5MEN1TP53
SCHEMBL9280441 0.71 PDK1 (0.33) MEN1TP53CYP3A4MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220532-B2 Chemical amplification type resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-22 US disclosed
US-7135268-B2 Using aromatic sulfonate compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-11-14 US disclosed
US-20050031984-A1 Chemical amplification type positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED 2005-02-10 US disclosed
US-20040053171-A1 Chemical amplification type resist composition SUMITOMO CHEMICAL COMPANY, LIMITED 2004-03-18 US disclosed
US-20040029037-A1 Amplification type positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-12 US disclosed